Pelacarsen Targets Lp(a), With Little Impact on LDL Cholesterol

Via Peters

A new method of distinguishing Lp(a) in blood samples has implications for LDL tests and patient care, researchers say. A new report helps shed some light on the effects of the novel antisense oligonucleotide pelacarsen (Novartis) on various cholesterol targets, including LDL cholesterol and lipoprotein(a). Pelacarsen, once known as AKCEA-APO(a)-LRX, […]